"10.1371_journal.pone.0053233","plos one","2013-01-24T00:00:00Z","Toshio Nishikimi; Hiroyuki Okamoto; Masahiro Nakamura; Naoko Ogawa; Kazukiyo Horii; Kiyoshi Nagata; Yasuaki Nakagawa; Hideyuki Kinoshita; Chinatsu Yamada; Kazuhiro Nakao; Takeya Minami; Yoshihiro Kuwabara; Koichiro Kuwahara; Izuru Masuda; Kenji Kangawa; Naoto Minamino; Kazuwa Nakao","Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Kyoto, Japan; Diagnostics Division, Shionogi & Co., Ltd, Osaka, Japan; Takeda Hospital Medial Examination Center, Kyoto, Japan; Department of Biochemistry National Cerebral and Cardiovascular Center Research Institute, Osaka, Japan; Department of Molecular Pharmacology, National Cerebral and Cardiovascular Center Research Institute, Osaka, Japan","Gave useful comments and discussion: K. Kamgawa K. Nakao. Conceived and designed the experiments: TN HO NM KH. Performed the experiments: MN NO K. Nagata. Analyzed the data: YN HK CY K. Nakao. Contributed reagents/materials/analysis tools: TM YK K. Koichiro IM. Wrote the paper: TN HO.","Hiroyuki Okamoto, Masahiro Nakamura, Naoko Ogawa, Kazukiyo Horii and Kiyoshi Nagata are employed by Shionogi& Co., Ltd. Shionogi Company previously developed the BNP kit and they may develop a new assay kit like a proBNP in the future. There are no further patents, products in development or marketed products to declare. This does not alter the authorsâ€š adherence to all the PLOS ONE policies on sharing data and materials.","2013","01","Toshio Nishikimi","TN",17,TRUE,4,3,4,2,TRUE,FALSE,TRUE,1,"14",FALSE
